Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  2015-02-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ja.2015.9PMID 25690361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.

  2012cited by this paper
• Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis

  2012cited by this paper
• Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

  2011cited by this paper
• Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.

  2010cited by this paper
• MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments

  2010cited by this paper
• Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous Drugs

  2010cited by this paper
• Genetic diversity of the Mycobacterium tuberculosis Beijing family in East Asia revealed through refined population structure analysis.

  2009cited by this paper
• A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

  2009cited by this paper
• Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosis

  2008cited by this paper
• Efflux-Related Resistance to Norfloxacin, Dyes, and Biocides in Bloodstream Isolates of Staphylococcus aureus

  2007cited by this paper
• Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria.

  2006cited by this paper
• Role of mycobacterial efflux transporters in drug resistance: an unresolved question.

  2006cited by this paper
• Chronic Inhibition of Cardiac Kir2.1 and hERG Potassium Channels by Celastrol with Dual Effects on Both Ion Conductivity and Protein Trafficking*♦

  2006cited by this paper
• Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography.

  2005cited by this paper
• Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis

  2004cited by this paper
• Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis

  2004cited by this paper
• The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds.

  2004cited by this paper
• The Multidrug Transporters Belonging to Major Facilitator Superfamily (MFS) in Mycobacterium tuberculosis

  2002cited by this paper
• Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis

  2001cited by this paper
• Potassium depolarization-induced cAMP stimulates somatostatin mRNA levels in cultured diencephalic neurons.

  2000cited by this paper
• Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.

  1999cited by this paper
• Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region.

  1998cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Erratum: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

  1997cited by this paper
• Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis.

  1996cited by this paper
• On the mechanism of rifampicin inhibition of RNA synthesis.

  1978cited by this paper

• Combating Multi-drug Resistant Mycobacterium Species by Efflux Pump Inhibitors: Contemporary Trends

  2025cites this paper
• In silico analysis of the functional implications of drug resistance associated mutations in Mycobacterium tuberculosis

  2025cites this paper
• Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis

  2025cites this paper
• Flurbiprofen restores rifampicin and isoniazid sensitivity in multidrug-resistant Mycobacterium tuberculosis putatively by inhibiting efflux pumps Rv0194 and Rv0933.

  2025cites this paper
• Efflux pumps positively contribute to rifampin resistance in rpoB mutant Mycobacterium tuberculosis

  2025cites this paper
• The importance of heteroresistance and efflux pumps in bedaquiline-resistant Mycobacterium tuberculosis isolates from Iran

  2024cites this paper
• Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities

  2024cites this paper
• Bidirectional ATP-driven transport of cobalamin by the mycobacterial ABC transporter BacA

  2024cites this paper
• Overexpression of efflux pump genes is one of the mechanisms causing drug resistance in Mycobacterium tuberculosis

  2023cites this paper
• Toxin-antitoxin Genes Expression in Multidrug-Resistant Mycobacterium tuberculosis Isolates under Drug Exposure.

  2023cites this paper
• Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c

  2023cites this paper
• An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance

  2022cites this paper
• What the Hel: recent advances in understanding rifampicin resistance in bacteria

  2022cites this paper
• Myoinositol and methyl stearate increases rifampicin susceptibility among drug‐resistant Mycobacterium tuberculosis expressing Rv1819c

  2022cites this paper
• Cholesterol Decorated Thiolated Stereocomplexed Nanomicelles for Improved Anti-Mycobacterial Potential via Efflux Pump and Mycothione Reductase Inhibition

  2022cites this paper
• Strain-Specific Behavior of Mycobacterium tuberculosis in Interruption of Autophagy Pathway in Human Alveolar Type II Epithelial A549 Cells

  2022cites this paper
• Modifications, biological origin and antibacterial activity of naphthalenoid ansamycins.

  2022cites this paper
• Deletion of rifampicin-inactivating mono-ADP-ribosyl transferase gene of Mycobacterium smegmatis globally altered gene expression profile that favoured increase in ROS levels and thereby antibiotic resister generation

  2022cites this paper
• Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance.

  2021cites this paper
• Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?

  2021cites this paper
• The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis

  2021influential citation
• Critical discussion on drug efflux in Mycobacterium tuberculosis

  2021influential citation
• Prospects and Obstacles for Clinical Use of the Inhibitors of Mycobacterium tuberculosis Efflux Pumps

  2021cites this paper
• PNA-mediated efflux inhibition as a therapeutic strategy towards overcoming drug resistance in Mycobacterium smegmatis.

  2021cites this paper
• Rifampicin Mono-Resistant Tuberculosis—A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control

  2021cites this paper
• Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi.

  2021cites this paper
• Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex.

  2021cites this paper
• Transcriptome analysis reveals the effect of high-grain pelleted and non-pelleted diets on ruminal epithelium of Hu-lamb.

  2021cites this paper
• Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules

  2020cites this paper
• Differential expression of resistant and efflux pump genes in MDR-TB isolates.

  2020cites this paper
• Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China

  2020cites this paper
• Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs

  2020cites this paper
• Determination of Drug Efflux Pump Efficiency in Drug-Resistant Bacteria Using MALDI-TOF MS

  2020cites this paper
• Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps

  2019cites this paper
• Clinical Pharmacology of Rifampin in Infants and Children

  2019cites this paper
• Mycobacterium tuberculosis Rv0191 is an efflux pump of major facilitator superfamily transporter regulated by Rv1353c.

  2019cites this paper
• Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis

  2018influential citation
• Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence

  2018cites this paper
• Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance

  2018cites this paper
• Updated and standardized genome-scale reconstruction of Mycobacterium tuberculosis H37Rv, iEK1011, simulates flux states indicative of physiological conditions

  2018cites this paper
• RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.

  2017cites this paper
• Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis

  2017cites this paper
• Mycobacterium tuberculosis Major Facilitator Superfamily Transporters

  2017cites this paper
• High efflux pump activity and gene expression at baseline linked to poor tuberculosis treatment outcomes

  2017influential citation
• Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of Mycobacterium tuberculosis

  2017cites this paper
• Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis

  2016cites this paper
• An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria

  2016cites this paper
• Development of efflux pump inhibitors in antituberculosis therapy.

  2016cites this paper
• Genetic determinants and evolution of drug resistance in Mycobacterium tuberculosis in Vietnam : toward new diagnostic tools

  2016cites this paper
• Genome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient

  2015cites this paper
• Drug Repurposing Patent Applications July–September 2015

  2015cites this paper
• Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

  2015cites this paper